HCA Healthcare Inc HCA Stock Analysis
- NYSE
- Stock
- Market closed · opens Monday 9:30 AM ET
$494.99 down $12.49, 2.46% at close Nov 6
Last close · Previous close $507.48
- Market cap
- $107.17BAt the Nov 6 close
- P/E ratio
- 16.42On last 12 months’ EPS
- Diluted EPS
- $30.14Last 12 months
- Dividend yield
- 0.62%Last 12 months
Price chart
$494.99down $12.49, 2.46%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$507.48Nov 5
- Volume1.46MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.44MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $353.99 to $556.52; now $494.99
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
HCA beat the S&P 500 in 5 of 7 periods.
| Period | HCA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | HCA: up 14.5% S&P 500: down 5.6% | HCA beat the S&P 500 by 20.1 percentage points Beat |
| 3M | HCA: up 21.3% S&P 500: down 4.1% | HCA beat the S&P 500 by 25.4 percentage points Beat |
| YTD | HCA: up 6.6% S&P 500: up 8.7% | HCA trailed the S&P 500 by 2.1 percentage points Trailed |
| 1Y | HCA: up 5.7% S&P 500: up 10.9% | HCA trailed the S&P 500 by 5.2 percentage points Trailed |
| Long term | ||
| 3Y | HCA: up 119.2% S&P 500: up 75.0% +29.9% vs +20.5% a year | HCA beat the S&P 500 by 44.2 percentage points Beat |
| 5Y | HCA: up 107.8% S&P 500: up 67.8% +15.8% vs +10.9% a year | HCA beat the S&P 500 by 40.0 percentage points Beat |
| 10Y | HCA: up 611.7% S&P 500: up 313.1% +21.7% vs +15.2% a year | HCA beat the S&P 500 by 298.6 percentage points Beat |
$10,000 invested in HCA 10 years ago (Nov 4, 2016) would be worth about $71,171 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
HCA beat the S&P 500 in 5 of 7 periods.
| Period | HCA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | HCA: up 14.5% S&P 500: down 5.6% | HCA beat the S&P 500 by 20.1 percentage points Beat |
| 3M | HCA: up 21.1% S&P 500: down 4.3% | HCA beat the S&P 500 by 25.4 percentage points Beat |
| YTD | HCA: up 6.0% S&P 500: up 7.8% | HCA trailed the S&P 500 by 1.8 percentage points Trailed |
| 1Y | HCA: up 5.0% S&P 500: up 9.7% | HCA trailed the S&P 500 by 4.7 percentage points Trailed |
| Long term | ||
| 3Y | HCA: up 114.3% S&P 500: up 68.8% +28.9% vs +19.1% a year | HCA beat the S&P 500 by 45.5 percentage points Beat |
| 5Y | HCA: up 99.4% S&P 500: up 56.9% +14.8% vs +9.4% a year | HCA beat the S&P 500 by 42.5 percentage points Beat |
| 10Y | HCA: up 557.1% S&P 500: up 252.6% +20.7% vs +13.4% a year | HCA beat the S&P 500 by 304.5 percentage points Beat |
$10,000 invested in HCA 10 years ago (Nov 4, 2016) would be worth about $65,710 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$545.13
Closing high on . Now 9.2% below that record.
Split-adjusted daily closes since Mar 10, 2011.
Stock splits
HCA hasn’t split since its price history begins in 2011.
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Sep 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
16.4×The Nov 6 close ÷ diluted EPS over the last 12 months ($30.14)
The range covers daily P/E ratios from Oct 28, 2021 to Nov 6, 2026, each based on the previous 12 months of earnings.
HCA trades at 16.4× its earnings over the last 12 months, above its 5-year median of 13.7×. In plain terms, buyers are paying about $16 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 1.4×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 10.6×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 0.99Last 12 months’ EPS growth
The P/E divided by the growth in diluted EPS over the last 12 months (+16.5% on the 12 months before). It looks backward: near 1 means the P/E roughly matches last year’s growth. Sites that use analysts’ growth forecasts show a different PEG.
PEG = P/E ÷ EPS growth (%) = 16.4 ÷ 16.5 - 5.57%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $158.68BAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Sep 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own HCA DCF in Excel. Value HCA Healthcare with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Sep 30, 2026. “Last 12 months” means the four quarters from Oct 1, 2025 to Sep 30, 2026, and balance-sheet figures are as of Sep 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $78.70Bup 5.8%
- Net income
- $6.78Bup 6.8%
- Diluted EPS
- $30.14up 16.5%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY24 (Dec 31, 2024) | $18.29B | $1.44B | $5.63 |
| Q1 FY25 (Mar 31, 2025) | $18.32B | $1.61B | $6.45 |
| Q2 FY25 (Jun 30, 2025) | $18.61B | $1.65B | $6.83 |
| Q3 FY25 (Sep 30, 2025) | $19.16B | $1.64B | $6.96 |
| Q4 FY25 (Dec 31, 2025) | $19.51B | $1.88B | $8.10 |
| Q1 FY26 (Mar 31, 2026) | $19.11B | $1.62B | $7.15 |
| Q2 FY26 (Jun 30, 2026) | $20.23B | $1.70B | $7.62 |
| Q3 FY26 (Sep 30, 2026) | $19.85B | $1.58B | $7.27 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $58.75B | $6.96B | $21.16 |
| FY22 (Dec 31, 2022) | $60.23B | $5.64B | $19.15 |
| FY23 (Dec 31, 2023) | $64.97B | $5.24B | $18.97 |
| FY24 (Dec 31, 2024) | $70.60B | $5.76B | $22.00 |
| FY25 (Dec 31, 2025) | $75.60B | $6.78B | $28.33 |
Margins
- Gross 42.8%
- Operating 15.3%
- Net 8.6%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $5.97BLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$11.17BLast 12 months
- Capital spending$5.20BLast 12 months
- 7.6%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $9.16BLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$681.00MLast 12 months
- Total returned$9.84BLast 12 months
165% of free cash flow
Balance sheet
- $2.19BAs of Sep 30, 2026
Cash plus short- and long-term marketable securities on the Sep 30, 2026 balance sheet.
- Total debt$52.43BAs of Sep 30, 2026
- Net debt$50.24BAs of Sep 30, 2026
- 0.82As of Sep 30, 2026
Current assets divided by current liabilities on the Sep 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio
Financial strength
- 7 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✓Return on assets improved: passed
- ✓Operating cash flow exceeded net income: passed
- ✗Long-term debt fell relative to assets: not passed
- ✗Current ratio improved: not passed
- ✓Share count didn’t rise: passed
- ✓Gross margin improved: passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- 10.9%Last 12 months
Over the last 12 months, HCA Healthcare’s net income was 10.9% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.000 |
| 2017 | $0.000 |
| 2018 | $1.40 |
| 2019 | $1.60 |
| 2020 | $1.04 |
| 2021 | $1.92 |
| 2022 | $2.24 |
| 2023 | $2.40 |
| 2024 | $2.64 |
| 2025 | $2.88 |
| 2026 (to date) | $2.34 |
Dividend details
- $3.06Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- 0.62%; 5-yr low 0.53%, 5-yr high 1.25%Last 12 months
Dividends paid over the last 12 months as a share of the Nov 6 close. The bar shows where that yield sits in its range over the past five years; the median was 0.79%.
- $0.78Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyQuarterly4 payments in the last 12 months
- 4 yearsThrough 2025
How many calendar years in a row the full-year amount has risen, through 2025.
- 10.2%Last 12 months
The share of earnings paid out as dividends over the last 12 months. Lower ratios leave more room to reinvest or raise the dividend.
Payout = Dividends per share ÷ Diluted EPS (both last 12 months)Payout ratio calculator
About HCA Healthcare Inc
HCA Holdings, Inc. (HCA) is a holding company whose affiliates owns and operates hospitals and related health care entities. HCA is a health care services companies in the United States. At December 31, 2011, it operated 163 hospitals, comprised of 157 general, acute care hospitals; five psychiatric hospitals, and one rehabilitation hospital. In addition, it operated 108 freestanding surgery centers. Its operations are structured into three geographically organized groups: the National, Southwest and Central Groups. At December 31, 2011, the National Group includes 64 hospitals located in Florida, South Carolina, southern Georgia, Alaska, California, Nevada, Utah and Idaho, the Southwest Group includes 46 hospitals located in Colorado, Texas, Oklahoma and the Wichita, Kansas market, and the Central Group includes 47 hospitals. During October 2011, the Company acquired the Colorado Health Foundation's (Foundation).In December 2011, it sold Palmyra Medical Center in Albany, Ga.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Tennessee, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- NYSE
- Asset type
- Common stock
- Price history since
HCA news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
HCA stock FAQ
What is HCA stock’s price today?
HCA Healthcare (HCA) traded at $494.99 at the close on , down $12.49 (2.46%) from the previous close of $507.48. Over the past 52 weeks it has traded between $353.99 and $556.52.
If you invested $1,000 in HCA 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in HCA on would be worth about $7,117 at the close on , a total return of +611.7%. The same $1,000 would be worth $2,078 if invested five years ago and $1,057 if invested one year ago. Past performance doesn’t predict future returns.
What is HCA Healthcare’s market cap?
HCA Healthcare’s market capitalization is about $107.2 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $494.99 (how market cap works). HCA Healthcare reported 216.50M shares outstanding at the end of its latest quarter ().
What is HCA’s P/E ratio?
HCA trades at 16.4 times its diluted earnings over the four quarters to ($30.14 per share), at the close. Over the past five years its P/E has ranged from 7.5 to 19.0, with a median of 13.7. (How the P/E ratio works.)
How much revenue does HCA Healthcare make?
HCA Healthcare reported $78.7 billion of revenue over the four quarters to , up 5.8% from the twelve months before. In its latest quarter (Q3 FY26, ended ) revenue was $19.8 billion, up 3.6% from a year earlier.
Is HCA Healthcare profitable?
Yes. HCA Healthcare earned $6.8 billion of net income over the four quarters to , a net margin of 8.6%, and its operating margin was 15.3% (what margins tell you).
What are HCA’s earnings per share?
HCA’s diluted earnings per share were $30.14 over the four quarters to , compared with $25.87 in the twelve months before. The latest quarter (Q3 FY26) brought $7.27 per share, against $6.96 a year earlier (how EPS works).
Does HCA pay a dividend?
Yes. HCA Healthcare pays a quarterly dividend. The most recent was $0.78 per share, with an ex-dividend date of . Over the last twelve months it paid $3.06 per share, a 0.62% yield at the close, and the full-year dividend has risen 4 years in a row (how dividend yield works).
Based on the last 12 months’ payments ($3.06 per share), and if the next 12 months match the last 12, 100 shares would receive about $306 over 12 months, and $1,000 over 12 months would take about 327 shares, roughly $161,862 at the close. Dividends can change.
What is HCA’s 52-week high and low?
Over the past 52 weeks HCA has traded as low as $353.99 and as high as $556.52. At $494.99 at the close on , it is 11.1% below that high and 39.8% above the low.
What is HCA’s all-time high?
HCA’s highest closing price was $545.13 on , adjusted for stock splits. At $494.99 at the close on , it is 9.2% below that record.
Has HCA stock ever split?
No. HCA hasn’t split since its price history begins in 2011.
How has HCA stock performed?
Including dividends and measured to the close on , HCA has returned +6.6% so far this year and +5.7% over the past year, and +107.8% over five years (+15.8% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is HCA Healthcare in?
HCA Healthcare is in the Healthcare sector and the Medical Care Facilities industry, and is headquartered in Tennessee, USA.
What exchange does HCA trade on?
HCA Healthcare trades on the NYSE under the ticker symbol HCA. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.